Kalmeijer 2002.
Methods | Double‐blind, randomised controlled trial | |
Participants | Orthopedic surgery patients. Both carriers and non‐carriers. Mupirocin: 95 carriers. Placebo: 86 carriers. No significant difference between both groups. | |
Interventions | Mupirocin or placebo. Twice daily from the day of admission (day before surgery) to the hospital until the day of surgery. | |
Outcomes | S. aureus infection rate. | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Low risk | Adequate |
Blinding? participants | Low risk | |
Blinding? investigator | Low risk | |
Blinding? outcome assessor | Low risk | |
Blinding? data analysis | Low risk | |
Intention to treat | Low risk | reported and confirmed |
Loss to follow up | High risk |